新西兰的临床试验使用新的PET-CT扫描技术,以更好地检测乳房癌。 Clinical trial in New Zealand uses new PET-CT scan tech to better detect lobular breast cancer.

在新西兰进行新的临床试验,目的是利用新技术,改进对第二常见类型包皮乳癌的诊断和治疗。 A new clinical trial in New Zealand aims to improve diagnosis and treatment of lobular breast cancer, the second most common type, using a new technology. 在新西兰乳腺癌基金会的资助下,它涉及50名病人,他们接受PET-CT扫描,并配有称为FAPI的放射tracer,以便更准确地检测癌症的规模和蔓延。 Funded by the Breast Cancer Foundation NZ, it involves 50 patients receiving PET-CT scans with a radiotracer called FAPI to more accurately detect the size and spread of cancer. 这有可能改变这一经常被白喉诊断的癌症的治疗方式。 This could potentially transform how this often-late-diagnosed cancer is treated.